Blueprint Medicines Appoints Daniella Beckman to its Board of Directors
"Daniella's wealth of experience in the biopharmaceutical sector brings new strength to our Board of Directors," said
"
About Blueprint Medicines
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, express or implied statements regarding plans, strategies, timelines and expectations for
View original content to download multimedia:https://www.prnewswire.com/news-releases/blueprint-medicines-appoints-daniella-beckman-to-its-board-of-directors-301441703.html
SOURCE
Media: Sarah Mena Guerrero, +1 (617) 714-6684, media@blueprintmedicines.com; Investor Relations: Kristin Hodous, +1 (617) 714-6674, ir@blueprintmedicines.com